Egyptian researchers loaded Juniperus phoenicea leaf extract into nanostructured lipid carriers that showed enhanced antibacterial activity against Acinetobacter baumannii and greater cytotoxicity than fluorouracil against lung cancer cells in laboratory assays.
Regional subgroup analyses were carried out for hypertension, diabetes and obesity, but only where a sufficient number of studies were available. The authors caution that these subgroup findings should not be generalized to all outcomes, and that pooled continental estimates…
A mouse study found that nitazoxanide loaded into chitosan nanoparticles reduced fecal and intestinal Cryptosporidium oocyst counts more than free nitazoxanide, with a non-significant improvement in mortality.
The answer to both questions was yes, with distinct mutational fingerprints emerging for each material. Mesoporous silica killed cells in a clean, dose-dependent fashion, while graphene oxide produced a messier toxicity profile—but both left measurable scars in a reporter…
Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates U.S. Biotech Day 2026 | November 16–17, 2026 | Philadelphia, PA Panel: "Bridging the Translational Gap: From Discovery Insights to Clinical Proof", November 16, 9:15–9:45 a.m. ET Company showcase: November…
Poly(I:C), a synthetic double-stranded RNA, durably suppressed NF1-associated optic pathway glioma growth in mice by engaging TLR3 and MDA5 pathways in microglia that converge on ERK signaling.
A new review argues that engineered nanomaterials interact with biology through a shared set of interfacial processes that determine their diagnostic, therapeutic, antimicrobial and environmental performance. News Source: Gregory Coleman. (October 29, 2026). How Bio–Nano Interfaces Are Rewriting the Rules of…
A Burkholderia strain isolated from Delhi's Yamuna River removed 68.9 percent of amoxicillin in a minimal medium within 14 days, with negligible loss in bacteria-free controls.
Researchers report generating human chemically induced pluripotent stem cells from umbilical cord-derived mesenchymal stem cells using an optimized small-molecule protocol under normal oxygen conditions. Subject of Research: Chemical reprogramming of human umbilical cord-derived mesenchymal stem cells into induced pluripotent stem…
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced today it has joined the Industry Resource Partnership (IRP) Program of the California Institute for Regenerative Medicine (CIRM), a state agency. The…
Labs, patents and what's next.
An article joins this feed when it matches these terms. Each one is also a search of its own.